Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Personalised Medicine 2015

Nitzan Rosenfeld's Biography

Nitzan Rosenfeld, Senior Group Leader, Cancer Research UK and CSO, Inivata Ltd.

Nitzan trained in Physics, and specialized in quantitative molecular biology, obtaining a Ph.D. in the field of Systems Biology from the Weizmann Institute of Science. In 2005 he joined Rosetta Genomics Limited, where he was head of Computational Biology and led development of molecular diagnostic tests. Since 2009 he is a group leader at the Cancer Research UK Cambridge Institute, now part of the University of Cambridge. His translational research group focuses on the application of circulating tumour DNA as a tool for cancer diagnostics and non-invasive genomics. In 2013 Nitzan was awarded the CRUK Future Leaders in Cancer Research prize, the British Association for Cancer Research Translational Research Award, and an ERC Starting Grant. In 2014, Nitzan and his colleagues founded Inivata, a clinical cancer genomics company that aims to harness the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients.

Nitzan Rosenfeld Image

Monitoring the Cancer Genome in Plasma using Circulating DNA

Tuesday, 12 May 2015 at 14:15

Add to Calendar ▼2015-05-12 14:15:002015-05-12 15:15:00Europe/LondonMonitoring the Cancer Genome in Plasma using Circulating DNAPersonalised Medicine 2015 in

Cell-free DNA in plasma contains circulating tumour DNA (ctDNA). This can be used as a non-invasive ‘liquid biopsy’ to assess cancer mutations, to monitor tumour burden, and to study tumour evolution.

Add to Calendar ▼2015-05-12 00:00:002015-05-13 00:00:00Europe/LondonPersonalised Medicine 2015Personalised Medicine 2015 in